New pilot aims to bring suicide prevention to Nepal's rural health posts

NCT ID NCT07362056

First seen Jan 25, 2026 · Last updated Jun 21, 2026 · Updated 19 times

Summary

This pilot study tests a suicide prevention package (PSuPP) for primary care providers in rural Nepal. The package includes training, screening tools, safety planning, and follow-up care coordination. Researchers will enroll 147 providers and patients to see if the approach is feasible and acceptable, with the goal of designing a larger future trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUICIDE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Primary care facilities

    RECRUITING

    Dolakhā, Nepal

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Suicide Prevention Package (PSuPP) - a set of training tools and care protocols for primary care providers

What this could lead to

If successful, this pilot could pave the way for a larger trial that may improve suicide risk detection and management in low-resource primary care settings.

What could go wrong

This is a small pilot study (147 participants) focused on feasibility, not on proving the package reduces suicides. Results may not generalize beyond rural Nepal.

Conditions

The condition(s) this trial relates to.

Suicide Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.